This topic contains a solution. Click here to go to the answer

Author Question: A 71-year-old patient has taken levodopa for Parkinson's disease for 2 weeks but reports no ... (Read 12 times)

kellyjaisingh

  • Hero Member
  • *****
  • Posts: 540
A 71-year-old patient has taken levodopa for Parkinson's disease for 2 weeks but reports no improvement in the symptoms. Select the nurse's best response.
 
  1. Stop the drug. If it has not been effective in 2 weeks, it is not likely to be beneficial.
  2. It may take several months for a response to occur. Continue the medication as prescribed.
  3. Double the dose to see if an effect will occur. Finding the correct dose takes many adjustments.
  4. Another agent will need to be added to the regimen now in order to manage your symptoms.

Question 2

A nurse is trying to evaluate understanding of dopamine agonists in a nursing student caring for a patient with Parkinson's disease.
 
  Which statement made by the student best demonstrates an understanding of the use of dopamine agonists in Parkinson's disease?
  a. Dopamine agonists are more effective than levodopa (Dopar).
  b. Dopamine agonists compete with dietary proteins in the intestines.
  c. Dopamine agonists are more likely to cause permanent and disabling dyskinesias.
  d. Non-ergot derivatives cause fewer side effects than ergot derivatives such as bromocriptine (Parlodel).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sarahccccc

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

Correct Answer: 2

Answer to Question 2

ANS: D
The non-ergot derivatives cause fewer side effects than the ergot derivatives, because the non-ergot drugs are selective for dopamine receptors. Ergot derivatives interact with alpha-adrenergic and serotonergic receptors in addition to dopamine receptors.
Dopamine agonists are not more effective than levodopa.
Dopamine agonists do not compete with dietary proteins in the intestines.
Dopamine agonists are not more likely to cause permanent and disabling dyskinesias.




kellyjaisingh

  • Member
  • Posts: 540
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


Kedrick2014

  • Member
  • Posts: 359
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

For a complete list of videos, visit our video library